ZAM-CS, a novel chimeric endolysin with enhanced stability and rapid action against methicillin-resistant Staphylococcus aureus
The rapid and dynamic action and high stability of ZAM-CS compared to other recombinant endolysins make it a suitable candidate for development to replace antibiotics targeting harmful Staphylococci, including MRSA.
Authors
- Farzaneh Azizmohseni
- Neda Soleimani (ORCID: https://orcid.org/0000-0001-5769-8452)
- Zahra Amini-Bayat
- Yasaman Ahmadbeigi (ORCID: https://orcid.org/0009-0003-5673-4185)
Institutions
- Iranian Research Organization for Science and Technology (IR)
- Shahid Beheshti University (IR)
Publication Details
- Journal
- BMC Microbiology
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1186/s12866-025-04074-5
- Citations
- 1
- Primary Topic
- Bacteriophages and microbial interactions
- Type
- article
- Field-Weighted Citation Impact
- 1.72
Funders
- Iranian Research Organization for Science and Technology